Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • ROOMS:

Upcoming Investor Conference and Presentation Schedule

CEOs heading to the Pitcher’s mound

DENVER, Colo. - June 8, 2022 - For many investors, investor conferences and CEO presentations are a unique opportunity to evaluate corporate leaders’ skillsets.

Investors should walk away from the CEO’s presentation believing that management has the following;

  • Capable of building the business
  • Committed to completing the necessary tasks and taking the company past the goal line
  • Have a competent team and/or network that will support the mission
  • Able to connect with investors

If the presentation checks all of those boxes increases the likelihood of earning their support.

Xeriant, Inc. (OTCQB: XERI)  distributed an advance media advisory two weeks ago regarding the Company’s planned press conference, tentatively scheduled for late June, for the purpose of announcing recent significant developments.

The aerospace company, dedicated to Advanced Air Mobility and associated specialty chemicals and materials, previously held a press conference to announce that it entered a joint venture ("JV") with XTI Aircraft Company ("XTI"), a privately held cleantech aviation company based in Englewood, Colorado, which announced that it has $2 billion in presales

The Xeriant joint venture with XTI received wide media coverage including;

Other noteworthy presentations include (All times are Eastern Time Zone):

Today, from 2:30 - 3:00, Matthew Moore, Co-Founder and CEO of InnerScope Hearing Technologies Inc. (OTC PINK: INND), and Mark Schmidt, President and CEO of Cyberlux Corporation (OTC PINK:CYBL), from 1:00 to 1:30 will be presenting at the 32nd Emerging Growth Conference (

Interested parties are asked to sign up to virtually attend the conference by registering for the conference here.

InnerScope Hearing Technologies Inc. is a leading Direct-to-Consumer (DTC) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and Personal Sound Amplifier Products (PSAPs) ("Hearing Products") dedicated to addressing the global demand for affordable hearing solutions. InnerScope's Hearing Products and its business model break through the persistent barriers that prevent access to effective hearing solutions.

Cyberlux Corporation (OTC PINK:CYBL) is a digital technology platform company providing breakthrough Digital Platform Solutions, including Platform-as-a-Service and Software-as-a-Service solutions, advanced Unmanned Aircraft Solutions, Advanced Lighting Solutions, Infrastructure and Renewable Energy Technology Solutions to U.S. government agencies, commercial customers, and international growth markets. Cyberlux is "Harnessing the Future" by leading digital transformation across global industries, driving operational growth through an accelerated acquisitions and joint ventures strategy, and continuously fueling growth with current and future technology developments.

For more information, please visit

For investor information, please contact:

Curaleaf Holdings, Inc. (OTCQX: CURLF), a leading international provider of consumer agricultural products, announced that members of Curaleaf's executive management team will be participating in the Oppenheimer 22nd Annual Consumer Growth and E-Commerce Conference that’s taking place June 14-15, 2022

Further details are available at visit Curaleaf's IR website at

As a high-growth agricultural company, Curaleaf currently operates in 22 states and employs over 5,700 team members, while Curaleaf International is the largest, in its space, vertically integrated company in Europe.

Northwest Biotherapeutics (OTCQB: NWBO) reported that Dr. Marnix Bosch made a presentation, in the Industry Expert Theater during the ASCO 2022 conference, discussing the Company's DCVax-L technology for personalized dendritic cell vaccines, the Sawston, UK facility, the manufacturing technology, the development of automation, and preparations for manufacturing scale-up, on June 4, 2022. In addition, a video presentation about the DCVax(R)-L clinical program was screened in the Company's exhibit booth in the ASCO Exhibit Hall.

Northwest Biotherapeutics is a biotechnology company developing DCVax(R) personalized immune therapies for solid tumor cancers; its lead program is a 331-patient Phase III trial of DCVax(R)-L for newly diagnosed and recurrent Glioblastoma multiforme (GBM), which is the most aggressive and lethal form of brain cancer, and is an "orphan disease."

The ASCO 2022 conference presentations are now available online at


This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, the  companies’ ability to continue to enhance their products and systems to address industry changes, their ability to expand their customer bases and retain existing customers, their ability to effectively compete in their market segments, the lack of public information on these companies, their ability to raise sufficient capital to fund their business operations, their ability to continue as a going concern, and a limited public market for their common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the companies’ control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Connect with 24/7 Market News on social media

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.


24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

Materials in this release are informational and should never be considered research. You must do your own due diligence by reading all available public information. This release is a corporate public statement, and believed to be reliable. The principle editor of 24/7 was contracted XERI for six months of coverage beginning November 18, 2020 and received warrants for the publication and dissemination of corporate information. The Principle editor also owns XERI shares purchased and will sell them at any time of his choosing without notice, which is viewed as a conflict of interest. 24/7 makes no representations and warranties to the completeness of materials provided and are subject to change without notice. 24/7 is not responsible for any gains or losses which result from our opinions or coverage expressed in our emails or our site and readers are cautioned that investing has risks and you may lose all or a portion of your money.

For further information on 24/7 Market News, please go to 

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.


24/7 Market News

Media Contact
Company Name: 24/7 Market News
Contact Person: Editor
Email: Send Email
Phone: 720.288.8495
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.